AI assistant
ABBOTT LABORATORIES — Director's Dealing 2004
Feb 24, 2004
29777_dirs_2004-02-24_0ac64d48-02bb-4b2b-aaad-b0248de3f144.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-02-20
Reporting Person: DEMPSEY WILLIAM G (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-02-20 | Common shares without par value | A | 8000 | $43.66 | Acquired | 133916 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-02-20 | Option (right to buy) | $43.66 | A | 55000 | Acquired | 2014-02-19 | common shares (55000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 9884 | Indirect |
Footnotes
F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2004.
F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07.